OptimizeRx Corporation
OPRX
$9.29
-$0.70-7.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -78.00K | -9.12M | -4.01M | -6.90M | -4.14M |
| Total Depreciation and Amortization | 1.56M | 1.00M | 1.00M | 996.00K | 1.25M |
| Total Amortization of Deferred Charges | 55.00K | 274.00K | 253.00K | 253.00K | 68.00K |
| Total Other Non-Cash Items | 4.40M | 8.47M | 2.90M | 3.16M | 11.60M |
| Change in Net Operating Assets | -5.75M | 1.17M | 633.00K | 4.61M | -15.03M |
| Cash from Operations | 198.00K | 1.79M | 782.00K | 2.12M | -6.26M |
| Capital Expenditure | -17.00K | -18.00K | -45.00K | -32.00K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 10.00K |
| Cash Acquisitions | -- | -- | -- | -- | -82.95M |
| Divestitures | -- | -- | -- | -- | 2.54M |
| Other Investing Activities | -103.00K | -74.00K | -40.00K | -121.00K | 54.40M |
| Cash from Investing | -120.00K | -92.00K | -85.00K | -153.00K | -26.00M |
| Total Debt Issued | -- | -- | -- | -- | 37.73M |
| Total Debt Repaid | -2.50M | -500.00K | -500.00K | -500.00K | -1.71M |
| Issuance of Common Stock | -- | -- | -- | -- | 15.00K |
| Repurchase of Common Stock | -324.00K | -32.00K | -415.00K | -140.00K | -146.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 300.00K |
| Cash from Financing | -2.82M | -532.00K | -915.00K | -640.00K | 36.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -1.00K |
| Net Change in Cash | -2.75M | 1.17M | -218.00K | 1.33M | 3.93M |